ArticleMolecular medicine reports2017
Pallidin protein in neurodevelopment and its relation to the pathogenesis of schizophrenia.
Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pallidin is a protein found throughout the nervous system and it has been linked to the development of schizophrenia. At the same time, it has been suggested that schizophrenia is a neurodevelopmental disease. The p38 protein participates in neuronal differentiation and apoptosis. We hypothesized pallidin and p38 play a role in neural system development and the pathogenesis of schizophrenia, and designed several experiments to test this possibility. During pull-down experiments GST-pallidin was able to bind His-Ndn (an HDAC3 binding protein) in vitro. In cells co-transfected with HDAC3 and p38, the transcriptional activity of p38 was significantly inhibited by HDAC3. When pallidin was overexpressed, the transcriptional activity of the endogenous HDAC3 improved significantly. Overexpression of pallidin-EGFP in HCT116 p38 wild-type cells increased the endogenous p21 protein and the mRNA levels. The decrease in the expression of endogenous p38 affected the differentiation of N2a cells. The lengths of the neurites generated in the experimental group were significantly shorter than those in the control group. We conclude that pallidin indirectly regulates the transcriptional activity of p38 during neurodevelopment by binding HDAC3 and changing its cellular localization, which leaves p38 uninhibited. Moreover, since pallidin can also affect neuronal differentiation and its variants seem to be related to an increased risk of schizophrenia, it is possible that both pallidin and p38 play a role in the pathogenesis of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.